Analyst Ratings For Cellectis (NASDAQ:CLLS)
Today, Guggenheim initiated coverage on Cellectis (NASDAQ:CLLS) with a Neutral .
Some recent analyst ratings include
- 3/16/2018-Guggenheim initiated coverage with a Neutral rating.
- 12/28/2017-Oppenheimer Reiterated Rating of Outperform.
- 10/29/2017-Jefferies Group Reiterated Rating of Buy.
- 10/6/2017-SunTrust Banks Reiterated Rating of Hold.
- 9/5/2017-Wells Fargo & Co Reiterated Rating of Outperform .
- 3/1/2017-Instinet initiated coverage with a Buy rating.
Recent Trading Activity for Cellectis (NASDAQ:CLLS)
Shares of Cellectis closed the previous trading session at 34.68 down -0.41 1.17% with 35.34000015258789 shares trading hands.
